🚨Holmes' Theranos Debut in WSJ Ignites Tech Hype
The rise and fall of Theranos, told in 140 characters
TL;DR
Elizabeth Holmes' Theranos made waves in 2013 with WSJ coverage, but by 2014, the company's tech was exposed as a sham. Investors and media fell for it, but the truth didn't take long to surface.
Elizabeth Holmes' Theranos made its national press debut in The Wall Street Journal in 2013, touting a revolutionary blood test. By 2014, Holmes was the youngest woman billionaire, riding the wave of tech success stories. However, the company's tech was a facade, with no peer-reviewed data and fake blood tests. The Wall Street Journal's John Carreyrou exposed the truth, revealing the company's lack of real innovation and its termination of deals with Walgreens. The documentary film captures Holmes' final days before incarceration, highlighting the stark contrast between hype and reality.
Key Points
Holmes' WSJ debut in 2013 titled 'A Drop of Blood, an Instant Diagnosis'
Holmes became youngest woman billionaire in 2014
Theranos' blood tests were fake, innovative tech didn't exist
Walgreens terminated its deal with Theranos, exposing the scam
Documentary film follows Holmes' final days before incarceration
Why It Matters
The rise and fall of Theranos highlights the dangers of unchecked hype and the importance of scientific rigor. If you're an investor or journalist covering tech startups, this story serves as a cautionary tale about the risks of investing in unproven technology and the need for thorough vetting.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,567 builders reading daily.